Themis Medicare Current Share Price | Themis Medicare Stock Screener
THEMISMED
Pharmaceuticals
Themis Medicare Current Stock Price Today
Live Share Price NSE
₹123.97
▲
4.12 (3.44%)
Live Share Price BSE
₹124.80
▲
6.35 (5.36%)
As of September 18, 2026, the live Themis Medicare share price (NSE: THEMISMED) is ₹123.97 on NSE and ₹124.80 on BSE, up 3.44% from the previous close, with shares trading between ₹118.82 and ₹126.58 in today's trading session, and a 52-week range of ₹66.07–₹142.55.
Browse THEMISMED cash flow statement to support your investment research.
Use the Themis Medicare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Themis Medicare Market Cap
₹1,181.18 Cr.
THEMISMED P/E Ratio (TTM)
30.41
Themis Medicare P/B Ratio
3.33
EPS (TTM)
₹0.12
Dividend Yield
0.38%
Debt to Equity
0.25
THEMISMED 52 Week High
₹142.55
Themis Medicare 52 Week Low
₹66.07
Operating Margin
-60.00%
Profit Margin
13.59%
THEMISMED Revenue (TTM)
₹184.00
EBITDA
₹44.00
Net Income
₹25.00
Total Assets
₹598.00
Total Equity
₹399.00
Themis Medicare Current Share Price Chart
Track the current Themis Medicare share price and stock price with an interactive chart. Analyse THEMISMED price trends, trading volume, historical performance, and volatility across different timeframes — the complete Themis Medicare stock quote in one place.
Themis Medicare Company Profile - Fundamental Screener
Screen Themis Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for THEMISMED shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083B01024
Themis Medicare Balance Sheet Screener
Screen THEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 598 | 588 | 566 | 514 | 428 | 371 | 350 | 314 | 305 | 289 |
| Current Assets | 305 | 304 | 293 | 265 | 214 | 186 | 181 | 150 | 143 | 124 |
| Fixed Assets | 169 | 172 | 168 | 162 | 144 | 133 | 116 | 123 | 126 | 124 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 33 | 29 | 34 | 35 | 31 | 24 | 12 | 9 | 12 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 399 | 403 | 378 | 339 | 288 | 219 | 183 | 158 | 169 | 152 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 389 | 393 | 369 | 330 | 278 | 209 | 174 | 149 | 160 | 143 |
Themis Medicare Income Statement Screener - Profit & Revenue Analysis
Screen Themis Medicare income statement and profit fundamentals.
Analyze THEMISMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Themis Medicare share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 184 | 87 | 97 | 83 | 99 | 73 | 95 | 123 | 130 | 103 | 89 | 111 | 103 | 85 | 96 |
| Expenses | 139 | 73 | 81 | 81 | 108 | 79 | 88 | 100 | 94 | 89 | 74 | 92 | 75 | 70 | 74 |
| EBITDA | 44 | 14 | 16 | 2 | -9 | -6 | 7 | 23 | 36 | 14 | 14 | 19 | 28 | 16 | 22 |
| Operating Profit % | -60.00% | 5.00% | 10.00% | -4.00% | -10.00% | -11.00% | 6.00% | 15.00% | 24.00% | 10.00% | 10.00% | 12.00% | 22.00% | 13.00% | 17.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 2 |
| Profit Before Tax | 39 | 9 | 10 | -4 | -14 | -11 | 2 | 18 | 31 | 9 | 8 | 14 | 23 | 10 | 18 |
| Tax | 14 | 0 | 0 | 0 | 0 | -2 | 1 | 4 | 7 | 2 | 1 | 3 | 4 | 2 | 4 |
| Net Profit | 25 | 9 | 10 | -4 | -14 | -10 | 1 | 14 | 25 | 7 | 7 | 11 | 18 | 8 | 13 |
| EPS | 2.67 | 0.96 | 1.10 | -0.39 | -1.54 | -1.05 | 0.06 | 1.55 | 2.68 | 0.72 | 0.80 | 12.30 | 19.77 | 9.13 | 14.47 |
Themis Medicare Cash Flow Screener - Liquidity Fundamentals
Screen THEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 35 | 22 | 16 | 34 | 57 | 0 | 11 | 8 | -2 | 26 |
| Investing Activities | -12 | -16 | -24 | -16 | -16 | -6 | -4 | 0 | -4 | -7 |
| Financing Activities | -26 | -9 | 0 | -18 | -26 | 7 | -10 | -9 | 5 | -13 |
| Net Cash Flow | -3 | -3 | -8 | 1 | 16 | 2 | -3 | -1 | 0 | 5 |
Themis Medicare Shareholding Pattern Screener
See Themis Medicare shareholding pattern with promoter, FII, and DII holdings.
Check Themis Medicare promoter holding and ownership changes for THEMISMED on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 67.11% | 67.11% | 67.15% | 67.15% | 67.15% | 67.11% | 67.15% | 67.15% |
| FII Holding | 0.11% | 0.01% | 0.14% | 0.10% | 0.06% | 0.05% | 0.03% | 0.05% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.73% | 23.57% | 23.93% | 24.14% | 23.97% | 24.02% | 23.31% | 23.42% |
| Other Holding | 9.05% | 9.30% | 8.77% | 8.60% | 8.80% | 8.81% | 9.49% | 9.37% |
| Shareholder Count | 21,818 | 21,267 | 17,889 | 19,335 | 22,490 | 22,576 | 11,295 | 11,322 |
Themis Medicare Share Dividend Screener - Share Yield Analysis
Check Themis Medicare dividend history with payout and yield data.
View Themis Medicare dividend details including ex-dates and amounts for THEMISMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.50 | 0.76% |
| 2024-March | ₹0.50 | 0.34% |
| 2023-March | ₹5.00 | 2.29% |
| 2022-March | ₹5.00 | 4.24% |
| 2021-March | ₹4.30 | 4.59% |
| 2020-March | ₹1.75 | 6.22% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Themis Medicare Stock Index Membership
See which indices include Themis Medicare stock.
Check THEMISMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
Themis Medicare Market Events Screener - Corporate Actions
Get Themis Medicare corporate actions including splits, bonuses, and buybacks.
Check Themis Medicare stock events that may affect THEMISMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -3.91% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 3.32% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 13.63% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 7.49% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.41% |
| 2025-09-12 | 2025-09-12 | Annual General Meeting | NA | -1.60% |
| 2025-09-04 | 2025-09-05 | Dividend | ₹ 0.50 /share | -41.32% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -8.21% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 25.64% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -15.07% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | 1.15% |
| 2024-07-22 | 2024-07-22 | Annual General Meeting | NA | 5.80% |
| 2024-07-12 | 2024-07-15 | Dividend | ₹ 0.50 /share | 9.31% |
| 2023-10-10 | 2023-10-10 | Split | 1:10 | 18.82% |
| 2023-09-01 | 2023-09-02 | Dividend | ₹ 5.00 /share | 2.89% |
Themis Medicare Competitors Screener - Peer Comparison
Screen THEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Themis Medicare Company Announcements - News Screener
Screen THEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-15 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-15 | Reg. 34 (1) Annual Report. | - |
| 2026-09-15 | Notice Of 56Th Annual General Meeting Scheduled On 30.09.2026 | - |
| 2026-08-17 | Announcements Under Regulation 30 (LODR)- Change Of Company Secretary / Compliance Officers E-Mail ID And Updation Of E-Mail Id Of RTA | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-13 | Announcement Under Regulation 30(5) Of SEBI (LODR)- Updates | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-08-13 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-08-13 | Results- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026. | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026. | - |
| 2026-08-05 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-31 | Board Meeting Intimation for Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 And Limited Review Reports Of The Statutory Auditors Thereon | - |
| 2026-07-31 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-21 | Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-21 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-21 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-17 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |